Abaloparatide, as an analog of the human recombinant parathyroid hormone-related protein (PTHrp) that selectively binds to the RG conformation of the parathyroid hormone type one receptor, may represent a successful option for postmenopausal women affected by osteoporosis (Hattersley et al., 2016; Miller et al., 2016). The gene discussed is PTHLH; the disease is osteoporosis.